Biomarkers
Àwòrán tí AI ṣe
Mizzou researchers identify molecules for early glaucoma detection
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.
Researchers have developed a blood test that detects pancreatic ductal adenocarcinoma with over 90% accuracy by combining four biomarkers, including two newly identified proteins. The test performs well even in early stages, potentially improving survival rates for this deadly cancer. The findings appear in Clinical Cancer Research.